Sigma Healthcare Ltd
S5YA
Company Profile
Business description
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
Contact
2125 Dandenong Road
Level 6
Clayton
MelbourneVIC3168
AUST: +61 392159215
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 January 2026
Employees
156
Stocks News & Analysis
stocks
Ask the analyst: Are IDP Education's woes temporary?
The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks
Is it time to buy the Magnificent Seven?
After the recent selloff, the bull market’s most in-demand stocks look much cheaper.
stocks
Chart of the week: Did ASX companies underwhelm or impress during earnings season?
The Chart of the Week looks at how our Fair Values changes for Australian companies during earnings season.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,966.60 | 36.00 | -0.45% |
| CAC 40 | 7,946.97 | 41.99 | -0.53% |
| DAX 40 | 22,523.35 | 153.06 | -0.67% |
| Dow JONES (US) | 41,062.19 | 288.74 | -0.70% |
| FTSE 100 | 8,525.21 | 15.76 | -0.18% |
| HKSE | 23,462.65 | 137.66 | -0.58% |
| NASDAQ | 17,429.04 | 219.41 | -1.24% |
| Nikkei 225 | 36,790.03 | 29.06 | -0.08% |
| NZX 50 Index | 12,209.05 | 40.50 | -0.33% |
| S&P 500 | 5,556.50 | 42.80 | -0.76% |
| S&P/ASX 200 | 7,749.10 | 37.10 | -0.48% |
| SSE Composite Index | 3,358.73 | 13.20 | -0.39% |